FDA Approves Donanemab for Early Alzheimer’s
The US Food and Drug Administration (FDA) has approved Eli Lilly's anti-amyloid donanemab (Kisunla) 350 mg/20 mL once-monthly injection for ...
Read moreThe US Food and Drug Administration (FDA) has approved Eli Lilly's anti-amyloid donanemab (Kisunla) 350 mg/20 mL once-monthly injection for ...
Read moreAn 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded that the investigational anti-amyloid donanemab ...
Read moreThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) will meet on ...
Read more© 2023 earth-news.info